Robert Faulkner

4.0k total citations · 1 hit paper
51 papers, 3.1k citations indexed

About

Robert Faulkner is a scholar working on Molecular Biology, Pharmacology and Molecular Medicine. According to data from OpenAlex, Robert Faulkner has authored 51 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Pharmacology and 9 papers in Molecular Medicine. Recurrent topics in Robert Faulkner's work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (9 papers) and Intraocular Surgery and Lenses (5 papers). Robert Faulkner is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (9 papers) and Intraocular Surgery and Lenses (5 papers). Robert Faulkner collaborates with scholars based in United States, Hungary and India. Robert Faulkner's co-authors include A. E. Mirsky, V. G. Allfrey, Uttam L. RajBhandary, Alexander Stuart, H. Gobind Khorana, Sheng‐Fuh Chang, R. M. Hoskinson, Rosa H. Huang, B. Michael Silber and Suman Wason and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Robert Faulkner

51 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS

1964 1.9k citations Robert Faulkner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Faulkner United States	22	2.3k	315	266	243	186	51	3.1k
Patricia V. Schoenlein United States	31	1.7k 0.7×	809 2.6×	125 0.5×	502 2.1×	80 0.4×	60	3.0k
Abdellah Allali‐Hassani Canada	34	3.3k 1.4×	405 1.3×	118 0.4×	247 1.0×	179 1.0×	60	4.1k
Dianne L. Newton United States	35	3.1k 1.4×	681 2.2×	179 0.7×	689 2.8×	89 0.5×	87	4.6k
Claude Vézina Canada	18	2.0k 0.9×	346 1.1×	588 2.2×	59 0.2×	186 1.0×	44	3.1k
Christina Kiel Spain	26	2.6k 1.1×	329 1.0×	155 0.6×	194 0.8×	92 0.5×	60	3.4k
Daman Saluja India	26	1.2k 0.5×	304 1.0×	115 0.4×	130 0.5×	192 1.0×	153	2.5k
Xian‐Hui He China	34	1.9k 0.8×	323 1.0×	195 0.7×	249 1.0×	180 1.0×	112	3.1k
Girish M. Shah Canada	33	2.7k 1.2×	1.6k 5.2×	89 0.3×	196 0.8×	161 0.9×	83	4.1k
Samuel K. Kulp United States	40	2.8k 1.2×	1.0k 3.3×	400 1.5×	352 1.4×	209 1.1×	120	4.4k
George R. Oliver United States	8	1.9k 0.8×	398 1.3×	111 0.4×	169 0.7×	129 0.7×	10	2.8k

Countries citing papers authored by Robert Faulkner

Since Specialization

Citations

This map shows the geographic impact of Robert Faulkner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Faulkner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Faulkner more than expected).

Fields of papers citing papers by Robert Faulkner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Faulkner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Faulkner. The network helps show where Robert Faulkner may publish in the future.

Co-authorship network of co-authors of Robert Faulkner

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Faulkner. A scholar is included among the top collaborators of Robert Faulkner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Faulkner. Robert Faulkner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wason, Suman, David B. Mount, & Robert Faulkner. (2014). Single-Dose, Open-Label Study of the Differences in Pharmacokinetics of Colchicine in Subjects with Renal Impairment, Including End-Stage Renal Disease. Clinical Drug Investigation. 34(12). 845–855. 43 indexed citations

Wason, Suman, Robert Faulkner, & Matthew W. Davis. (2012). Are Dosing Adjustments Required for Colchicine in the Elderly Compared with Younger Patients?. Advances in Therapy. 29(6). 551–561. 13 indexed citations

Faulkner, Robert, Najam A. Sharif, Kenneth Sall, et al.. (2010). Aqueous Humor Concentrations of Bimatoprost Free Acid, Bimatoprost and Travoprost Free Acid in Cataract Surgical Patients Administered Multiple Topical Ocular Doses of LUMIGAN ^® or TRAVATAN ^®. Journal of Ocular Pharmacology and Therapeutics. 26(2). 147–156. 29 indexed citations

Lindstrom, Richard L., Stephen S. Lane, Andrew J. Cottingham, et al.. (2010). Conjunctival Concentrations of a New Ophthalmic Solution Formulation of Moxifloxacin 0.5% in Cataract Surgery Patients. Journal of Ocular Pharmacology and Therapeutics. 26(6). 591–595. 4 indexed citations

Hariprasad, Seenu M., et al.. (2009). Periocular Distribution of Nepafenac and Amfenac after Topical Administation of Nepafenac in the Rabbit. Investigative Ophthalmology & Visual Science. 50(13). 5999–5999. 1 indexed citations

Jasek, Mark C, David C. Dahlin, David J. Kay, et al.. (2007). Pharmacokinetics of CIPRODEX® otic in pediatric and adolescent patients. International Journal of Pediatric Otorhinolaryngology. 72(1). 97–102. 10 indexed citations

Katz, Harold R., Samuel Masket, Stephen S. Lane, et al.. (2005). Absorption of Topical Moxifloxacin Ophthalmic Solution Into Human Aqueous Humor. Cornea. 24(8). 955–958. 50 indexed citations

Whitson, Jess T., Robert Faulkner, Michael A. Curtis, et al.. (2005). Concentrations of Betaxolol in Ocular Tissues of Patients with Glaucoma and Normal Monkeys after 1 Month of Topical Ocular Administration. Investigative Ophthalmology & Visual Science. 47(1). 235–235. 33 indexed citations

Katz, Harold R., Stephen S. Lane, Samuel Masket, et al.. (2004). Human Aqueous Humor Concentrations of Moxifloxacin Following Two Multiple–Dose Topical Ocular Dosing Regimens of Vigamox®.. Investigative Ophthalmology & Visual Science. 45(13). 4926–4926. 2 indexed citations

10.

Curtis, Michael A., et al.. (2002). Determination of travoprost and travoprost free acid in human plasma by electrospray HPLC/MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 28(2). 199–208. 13 indexed citations

11.

Faulkner, Robert, et al.. (2002). Safety and Pharmacokinetics of Travoprost a Potent Prostaglandin F (FP) Receptor Agonist, in Patients With Renal and Hepatic Impairment. Investigative Ophthalmology & Visual Science. 43(13). 4106–4106. 1 indexed citations

12.

Johnson, Curtis A., Charles E. Halstenson, J S Kelloway, et al.. (1992). Single-dose pharmacokinetics of piperacillin and tazobactam in patients with renal disease. Clinical Pharmacology & Therapeutics. 51(1). 32–41. 55 indexed citations

13.

Nuernberg, Bernd, et al.. (1989). Rapid quantitation of methotrexate and its metabolites in human serum, urine and bile, using solid-phase extraction and high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 487(2). 476–482. 30 indexed citations

14.

Faulkner, Robert, et al.. (1989). Bioequivalency of oral suspension formulations of cefixine. Biopharmaceutics & Drug Disposition. 10(2). 205–211. 2 indexed citations

15.

Bialer, Meir, et al.. (1988). In vitro protein binding interaction studies involving cefixime. Biopharmaceutics & Drug Disposition. 9(3). 315–320. 2 indexed citations

16.

Faulkner, Robert, et al.. (1988). Absolute Bioavailability of Cefixime in Man. The Journal of Clinical Pharmacology. 28(8). 700–706. 46 indexed citations

17.

Faulkner, Robert, et al.. (1987). Pharmacokinetics of Cefixime After Once‐a‐Day and Twice‐a‐Day Dosing to Steady State. The Journal of Clinical Pharmacology. 27(10). 807–812. 20 indexed citations

18.

Faulkner, Robert, et al.. (1984). Hemodialysis of Doxepin and Desmethyldoxepin in Uremic Patients. Artificial Organs. 8(2). 151–155. 6 indexed citations

19.

Huang, Rosa H. & Robert Faulkner. (1980). Lipid-Protein Interactions in the Multiple Forms of Monoamine Oxidases: Lipases as Probes Using Purified Intact Rat Brain Mitochondria. Molecular Pharmacology. 18(2). 267–273. 21 indexed citations

20.

Faulkner, Robert & John P. Lambooy. (1961). Intestinal Synthesis of Riboflavin in the Rat. Journal of Nutrition. 75(4). 373–378. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact